<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>McDonald’s takes on Starbucks, Chipotle with big new menu debuts — Live Feed</title><link>https://www.live-feeds.com/feed/mcdonald-s-takes-on-starbucks-chipotle-with-big-new-menu-debuts</link><atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.live-feeds.com/feed/mcdonald-s-takes-on-starbucks-chipotle-with-big-new-menu-debuts/rss.xml" rel="self" type="application/rss+xml"/><description>Continuously updated, source-cited coverage.</description>
<item><title>McDonald's tests new menu items to attract GLP-1 drug users</title><link>https://www.live-feeds.com/feed/mcdonald-s-takes-on-starbucks-chipotle-with-big-new-menu-debuts</link><guid isPermaLink="false">https://www.live-feeds.com/feed/mcdonald-s-takes-on-starbucks-chipotle-with-big-new-menu-debuts#u85646</guid><pubDate>Sat, 26 Sep 2026 23:46:22 +0000</pubDate><description>McDonald&amp;#039;s is exploring menu expansions to attract health-conscious customers and users of GLP-1 weight loss drugs like Ozempic. The company is considering the introduction of burger bowls, egg bites, and grilled chicken to maintain appeal as appetite-suppressing medications become more common. These debuts place the fast-food chain in direct competition with the product offerings of Starbucks and Chipotle.Why it mattersThe rise of GLP-1 medications has created a shift in consumer eating habits by reducing hunger and cravings. McDonald&amp;#039;s is adapting its menu to prevent losing custome</description></item>
</channel></rss>